ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » District of Columbia » Internal Medicine

Top Internal Medicine Prescribers in District of Columbia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SHEWIT BEZABEH MD

Internal Medicine

234

$3,346

163
65 are 65+

14%
patients receiving schedule two controlled substances

Avg: 4%

44%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 29%

$14
Average prescription price

Avg: $77

FIDELIS DOH MD

Internal Medicine

291

$20.8K

51
0 are 65+

35%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 29%

$72
Average prescription price

Avg: $77

FERDINAND CHUA MD

Internal Medicine

4,064

$242K

134
110 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

26%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$60
Average prescription price

Avg: $77

SHADI SOUFI M.D.

Internal Medicine

7,316

$469K

335
205 are 65+

18%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 29%

$64
Average prescription price

Avg: $77

ANDRE MICHALAK M,D.

Internal Medicine

5,995

$334K

277
221 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

22%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$56
Average prescription price

Avg: $77

EDGER POTTER MD

Internal Medicine

3,313

$217K

79
64 are 65+

23%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$65
Average prescription price

Avg: $77

AMY KOSSOFF M.D.

Internal Medicine

1,478

$150K

85
21 are 65+

19%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$102
Average prescription price

Avg: $77

POUNEH NOURI MD

Internal Medicine

2,817

$366K

168
63 are 65+

26%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$130
Average prescription price

Avg: $77

ASHWINI SARDANA MD

Internal Medicine

449

$8,255

243
130 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

30%
patients receiving schedule three controlled substances

Avg: 5%

17%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 29%

$18
Average prescription price

Avg: $77

JEFFREY MAZIQUE M.D.

Internal Medicine

1,801

$70.1K

124
77 are 65+

16%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 29%

$39
Average prescription price

Avg: $77

GORDON RAMSAY M.D.

Internal Medicine

2,531

$151K

138
75 are 65+

21%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$60
Average prescription price

Avg: $77

ROBERT JAYES M.D.

Internal Medicine

4,342

$225K

121
110 are 65+

26%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 29%

$52
Average prescription price

Avg: $77

FARZAM AYAZI

Internal Medicine

2,626

$170K

188
98 are 65+

23%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$65
Average prescription price

Avg: $77

DAGOBERT SIMO MD

Internal Medicine

614

$20.2K

42
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 29%

$33
Average prescription price

Avg: $77

SASSAN TAGHIZADEHMOGHADDAM M.D.

Internal Medicine

1,633

$95.3K

87
63 are 65+

15%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 29%

$58
Average prescription price

Avg: $77

MARTA SCHNEIDER M.D.

Internal Medicine

9,401

$556K

277
263 are 65+

14%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 29%

$59
Average prescription price

Avg: $77

EMIMANUEL BROWN M.D.

Internal Medicine

5,366

$256K

257
162 are 65+

21%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 29%

$48
Average prescription price

Avg: $77

CARMELLA COLE MD

Internal Medicine

4,350

$394K

279
164 are 65+

15%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$91
Average prescription price

Avg: $77

RACHEL KON MD

Internal Medicine

854

$59.6K

76
40 are 65+

18%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$70
Average prescription price

Avg: $77

CHRISTOPHER MCMACKIN MD

Internal Medicine

3,147

$934K

85
50 are 65+

19%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 29%

$297
Average prescription price

Avg: $77

RICHARD MCCLENDON

Internal Medicine

5,747

$350K

211
96 are 65+

26%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$61
Average prescription price

Avg: $77

RONALD DISTAJO M.D., M.P.H.

Internal Medicine

2,535

$118K

244
125 are 65+

16%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 29%

$47
Average prescription price

Avg: $77

EMMANUEL MBUALUNGU MD

Internal Medicine

8,091

$527K

324
252 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$65
Average prescription price

Avg: $77

RAFIC JARRAH MD

Internal Medicine

6,882

$459K

245
155 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 29%

$67
Average prescription price

Avg: $77

JERRY EARLL

Internal Medicine

6,550

$363K

115
113 are 65+

22%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 29%

$55
Average prescription price

Avg: $77

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank